首页 > 最新文献

CVIR Endovascular最新文献

英文 中文
Periarticular cooling reduces non-target perfusion in genicular artery embolization: a quantitative angiographic study. 关节周围冷却减少非靶灌注在膝动脉栓塞:定量血管造影研究。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-26 DOI: 10.1186/s42155-025-00597-0
Alice M Jacob, Alexander M C Böhner, Narine Mesropyan, Anna-Maria Odenthal, Alexander Isaak, Patrick Kupczyk, Daniel Kuetting, Julian Luetkens, Carsten Meyer, Tatjana Dell

Background: Genicular artery embolization (GAE) is an emerging, effective pain treatment for symptomatic knee osteoarthritis. A potential concern of this procedure is non-target embolization of cutaneous and subcutaneous vessels, which can lead to severe skin complications such as necrosis. To mitigate this risk, some operators use periarticular cooling with the rationale of inducing vasoconstriction. The vasoconstrictive effect on non-target subcutaneous vessels caused by cooling has, however, not yet been objectively demonstrated. This study aims to provide the first objective evidence for this common safety maneuver.

Methodology: This retrospective analysis is based on a cohort of 36 patients (39 knees). The study evaluated a total of 49 selective angiographies of medial or lateral genicular arteries, which were stratified based on the presence of a superficial blush. Three cohorts were defined for comparison: 1) The Cooling Cohort, comprising 20 angiographies (from 10 knees) that showed a blush and were treated with periarticular cooling. 2) The Blush-Control Cohort, consisting of 18 angiographies (from 18 knees) with a blush but without a cooling maneuver. 3) The No-Blush Control Cohort (11 knees). The blush area on DSA was quantitatively analyzed for both groups with a superficial blush; in the Cooling Cohort, the area was compared before and after the intervention, while the baseline blush was quantified for the Blush-Control Cohort. Skin-related adverse events were systematically recorded and compared at the patient level across all three cohorts.

Results: The application of periarticular cooling resulted in a significant reduction in the mean blush area from 464.8 ± 447.6 mm2 to 240.1 ± 208.2 mm2 (p = 0.012), corresponding to an average reduction of 73.8% (p = 0.0006). Patients receiving cooling showed significantly fewer skin alterations than the blush-control group [median score 1 vs 2, p = 0.0174].

Conclusion: Periarticular cooling is a simple, non-invasive, and effective technique that significantly reduces quantifiable non-target cutaneous perfusion during GAE. Our work provides objective evidence supporting its use as a standard safety-enhancing maneuver to minimize the risk of skin-related complications.

背景:膝动脉栓塞术(GAE)是一种新兴的、有效的治疗症状性膝骨关节炎疼痛的方法。该手术的一个潜在问题是皮下和皮下血管的非靶栓塞,这可能导致严重的皮肤并发症,如坏死。为了降低这种风险,一些作业者采用关节周围冷却,其原理是诱导血管收缩。然而,冷却对非靶皮下血管的收缩作用尚未得到客观证明。本研究旨在为这种常见的安全操作提供第一个客观证据。方法:回顾性分析基于36例患者(39个膝关节)的队列。该研究评估了49个选择性膝内侧或外侧动脉血管造影术,这些血管造影术是基于浅表腮红的存在而分层的。定义了三个队列进行比较:1)冷却队列,包括20个血管造影(来自10个膝盖),显示红肿并接受关节周围冷却治疗。2)腮红对照组,包括18张血管造影术(来自18个膝盖),有腮红但没有冷却操作。3)无脸红对照组(11膝)。定量分析两组浅表腮红在DSA上的腮红面积;在降温组中,对干预前后的腮红面积进行比较,而在腮红控制组中,对基线腮红进行量化。系统地记录皮肤相关不良事件,并在患者水平上对所有三个队列进行比较。结果:应用关节周围冷却使平均腮红面积从464.8±447.6 mm2显著减少到240.1±208.2 mm2 (p = 0.012),相当于平均减少73.8% (p = 0.0006)。接受降温治疗的患者皮肤变化明显少于脸红对照组[中位评分1 vs 2, p = 0.0174]。结论:关节周围冷却是一种简单、无创、有效的技术,可显著减少GAE期间可量化的非靶皮肤灌注。我们的工作提供了客观证据,支持其作为标准的安全增强操作,以尽量减少皮肤相关并发症的风险。
{"title":"Periarticular cooling reduces non-target perfusion in genicular artery embolization: a quantitative angiographic study.","authors":"Alice M Jacob, Alexander M C Böhner, Narine Mesropyan, Anna-Maria Odenthal, Alexander Isaak, Patrick Kupczyk, Daniel Kuetting, Julian Luetkens, Carsten Meyer, Tatjana Dell","doi":"10.1186/s42155-025-00597-0","DOIUrl":"10.1186/s42155-025-00597-0","url":null,"abstract":"<p><strong>Background: </strong>Genicular artery embolization (GAE) is an emerging, effective pain treatment for symptomatic knee osteoarthritis. A potential concern of this procedure is non-target embolization of cutaneous and subcutaneous vessels, which can lead to severe skin complications such as necrosis. To mitigate this risk, some operators use periarticular cooling with the rationale of inducing vasoconstriction. The vasoconstrictive effect on non-target subcutaneous vessels caused by cooling has, however, not yet been objectively demonstrated. This study aims to provide the first objective evidence for this common safety maneuver.</p><p><strong>Methodology: </strong>This retrospective analysis is based on a cohort of 36 patients (39 knees). The study evaluated a total of 49 selective angiographies of medial or lateral genicular arteries, which were stratified based on the presence of a superficial blush. Three cohorts were defined for comparison: 1) The Cooling Cohort, comprising 20 angiographies (from 10 knees) that showed a blush and were treated with periarticular cooling. 2) The Blush-Control Cohort, consisting of 18 angiographies (from 18 knees) with a blush but without a cooling maneuver. 3) The No-Blush Control Cohort (11 knees). The blush area on DSA was quantitatively analyzed for both groups with a superficial blush; in the Cooling Cohort, the area was compared before and after the intervention, while the baseline blush was quantified for the Blush-Control Cohort. Skin-related adverse events were systematically recorded and compared at the patient level across all three cohorts.</p><p><strong>Results: </strong>The application of periarticular cooling resulted in a significant reduction in the mean blush area from 464.8 ± 447.6 mm<sup>2</sup> to 240.1 ± 208.2 mm<sup>2</sup> (p = 0.012), corresponding to an average reduction of 73.8% (p = 0.0006). Patients receiving cooling showed significantly fewer skin alterations than the blush-control group [median score 1 vs 2, p = 0.0174].</p><p><strong>Conclusion: </strong>Periarticular cooling is a simple, non-invasive, and effective technique that significantly reduces quantifiable non-target cutaneous perfusion during GAE. Our work provides objective evidence supporting its use as a standard safety-enhancing maneuver to minimize the risk of skin-related complications.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"73"},"PeriodicalIF":1.5,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145151943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of Trans-collateral revascularization of infrapopliteal vessels: A Single-center retrospective study. 经侧支腘下血管重建术的有效性和安全性:一项单中心回顾性研究。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-26 DOI: 10.1186/s42155-025-00595-2
Yoshinori Tsubakimoto, Jun Shiraishi, Daisuke Usuki, Shin Takiuchi, Satoru Otsuji

Background: Endovascular therapy (EVT) has become a key revascularization strategy for patients with chronic limb-threatening ischemia (CLTI), especially in cases involving infrapopliteal (IP) chronic total occlusions (CTOs), which are often challenging to treat using standard antegrade approaches alone. Trans-collateral angioplasty (TCA) is a retrograde technique that accesses the distal true lumen via collateral vessels when conventional methods are unsuccessful. However, clinical evidence regarding the efficacy and safety of TCA remains insufficient. This study aimed to evaluate the efficacy and safety of TCA as a retrograde approach during EVT for IP CTO lesions.

Results: This retrospective single-center study included 44 IP CTO lesions in patients who underwent TCA between January 2020 and December 2022, after excluding 18 lesions treated solely with the pedal-plantar loop technique. The mean patient age was 78.8 years, and 81.8% had diabetes, 79.5% had chronic kidney disease, and 31.8% were on dialysis. EVT success was achieved in 95.5% (95% CI: 84.9-98.7) of lesions. TCA alone achieved lesion crossing in 70.5% (95% CI: 55.8-81.8), while distal puncture was required in 13.6% (95% CI: 6.4-27.0) of cases. Various crossing techniques, including the rendezvous technique and reverse subintimal tracking, were conducted. Collateral vessel-related complications occurred in 11.3% (5 lesions; 95% CI: 5.0-24.6), including injury in 6.8%, and occlusion and spasm in 2.3%. No vessel dissections occurred. The overall incidence of perioperative complications within 30 days was 20.5% (95% CI: 11.3-34.2), most commonly gastrointestinal bleeding and stroke. At one year, the rate of freedom from target lesion revascularization was 45.4%, and amputation-free survival was 84.0%.

Conclusions: Our findings suggest that TCA can be a feasible and relatively safe retrograde strategy for complex IP CTO lesions when antegrade wiring fails. It is associated with high procedural success and a low incidence of collateral vessel-related complications, supporting its use in selected cases of CLTI.

背景:血管内治疗(EVT)已成为慢性肢体威胁性缺血(CLTI)患者的关键血运重建策略,特别是涉及膝下(IP)慢性全闭塞(CTOs)的病例,这种情况通常难以仅使用标准顺行入路治疗。经侧支血管成形术(TCA)是一种逆行技术,当传统方法不成功时,通过侧支血管进入远端真腔。然而,关于TCA的有效性和安全性的临床证据仍然不足。本研究旨在评估TCA逆行入路治疗IP CTO病变EVT的有效性和安全性。结果:这项回顾性单中心研究包括了2020年1月至2022年12月期间接受TCA治疗的44例IP CTO病变,排除了18例仅用足底环技术治疗的病变。患者平均年龄为78.8岁,81.8%患有糖尿病,79.5%患有慢性肾脏疾病,31.8%接受透析治疗。EVT的成功率为95.5% (95% CI: 84.9-98.7)。70.5% (95% CI: 55.8-81.8)的病例仅通过TCA实现病灶交叉,13.6% (95% CI: 6.4-27.0)的病例需要远端穿刺。进行了各种交叉技术,包括交会技术和反向内膜下跟踪。侧枝血管相关并发症发生率为11.3%(5个病变;95% CI: 5.0-24.6),包括损伤6.8%,闭塞和痉挛2.3%。无血管夹层发生。30天内围手术期并发症的总发生率为20.5% (95% CI: 11.3-34.2),最常见的是胃肠道出血和脑卒中。一年后,目标病灶血运重建的自由率为45.4%,无截肢生存率为84.0%。结论:我们的研究结果表明,当顺行线路失败时,TCA是一种可行且相对安全的逆行治疗复杂IP CTO病变的策略。它具有较高的手术成功率和较低的侧支血管相关并发症发生率,支持其在特定CLTI病例中的应用。
{"title":"Efficacy and safety of Trans-collateral revascularization of infrapopliteal vessels: A Single-center retrospective study.","authors":"Yoshinori Tsubakimoto, Jun Shiraishi, Daisuke Usuki, Shin Takiuchi, Satoru Otsuji","doi":"10.1186/s42155-025-00595-2","DOIUrl":"10.1186/s42155-025-00595-2","url":null,"abstract":"<p><strong>Background: </strong>Endovascular therapy (EVT) has become a key revascularization strategy for patients with chronic limb-threatening ischemia (CLTI), especially in cases involving infrapopliteal (IP) chronic total occlusions (CTOs), which are often challenging to treat using standard antegrade approaches alone. Trans-collateral angioplasty (TCA) is a retrograde technique that accesses the distal true lumen via collateral vessels when conventional methods are unsuccessful. However, clinical evidence regarding the efficacy and safety of TCA remains insufficient. This study aimed to evaluate the efficacy and safety of TCA as a retrograde approach during EVT for IP CTO lesions.</p><p><strong>Results: </strong>This retrospective single-center study included 44 IP CTO lesions in patients who underwent TCA between January 2020 and December 2022, after excluding 18 lesions treated solely with the pedal-plantar loop technique. The mean patient age was 78.8 years, and 81.8% had diabetes, 79.5% had chronic kidney disease, and 31.8% were on dialysis. EVT success was achieved in 95.5% (95% CI: 84.9-98.7) of lesions. TCA alone achieved lesion crossing in 70.5% (95% CI: 55.8-81.8), while distal puncture was required in 13.6% (95% CI: 6.4-27.0) of cases. Various crossing techniques, including the rendezvous technique and reverse subintimal tracking, were conducted. Collateral vessel-related complications occurred in 11.3% (5 lesions; 95% CI: 5.0-24.6), including injury in 6.8%, and occlusion and spasm in 2.3%. No vessel dissections occurred. The overall incidence of perioperative complications within 30 days was 20.5% (95% CI: 11.3-34.2), most commonly gastrointestinal bleeding and stroke. At one year, the rate of freedom from target lesion revascularization was 45.4%, and amputation-free survival was 84.0%.</p><p><strong>Conclusions: </strong>Our findings suggest that TCA can be a feasible and relatively safe retrograde strategy for complex IP CTO lesions when antegrade wiring fails. It is associated with high procedural success and a low incidence of collateral vessel-related complications, supporting its use in selected cases of CLTI.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"72"},"PeriodicalIF":1.5,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145152007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A few final thoughts as outgoing editor-in-chief. 作为即将卸任的总编,我有一些最后的想法。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-09-01 DOI: 10.1186/s42155-025-00598-z
Jim A Reekers
{"title":"A few final thoughts as outgoing editor-in-chief.","authors":"Jim A Reekers","doi":"10.1186/s42155-025-00598-z","DOIUrl":"10.1186/s42155-025-00598-z","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"71"},"PeriodicalIF":1.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bifurcated hepatocaval stent reconstruction for treatment of hepatic venous outflow obstruction in orthotopic liver transplantation. 原位肝移植中肝静脉流出梗阻的肝腔分岔支架重建。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-08-29 DOI: 10.1186/s42155-025-00590-7
Jonathan C Giang, Dillon M Brown, Jeffrey Forris Beecham Chick, Eric J Monroe, David S Shin, Mina S Makary
{"title":"Bifurcated hepatocaval stent reconstruction for treatment of hepatic venous outflow obstruction in orthotopic liver transplantation.","authors":"Jonathan C Giang, Dillon M Brown, Jeffrey Forris Beecham Chick, Eric J Monroe, David S Shin, Mina S Makary","doi":"10.1186/s42155-025-00590-7","DOIUrl":"10.1186/s42155-025-00590-7","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"70"},"PeriodicalIF":1.5,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12397019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Portal vein stent to save the day. 门静脉支架挽救了生命。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-08-29 DOI: 10.1186/s42155-025-00586-3
Panagiotis Grigoropoulos, Vasilina Tsemelidi, Orfeas Varvarelis, Antonios Vezakis, Achilles Chatziioannou, Miltiadis Krokidis

Background: Post-operative portal vein stenosis/occlusion is a relatively common and life-threatening condition. Clinical outcomes depend on the early diagnosis and the appropriate management.

Case presentation: A 78-year-old female developed portal vein high grade stenosis after resection of an ampullary cholangiocarcinoma. The patient presented with acute liver failure and impaired coagulation function. Imaging confirmed transient ischemic changes of the hepatic parenchyma. Salvage attempt with a portal venous stent was decided to prevent irreversible liver damage. The procedure was successful with a satisfactory clinical outcome.

Conclusions: The paper offers a summary of the clinical benefit from percutaneous portal venous stent placement in case of post operative high grade portal vein stenosis in a patient with acute liver failure.

背景:术后门静脉狭窄/闭塞是一种较为常见且危及生命的疾病。临床结果取决于早期诊断和适当的治疗。病例介绍:一位78岁女性在切除壶腹胆管癌后出现门静脉高度狭窄。患者表现为急性肝功能衰竭和凝血功能受损。影像学证实肝实质短暂性缺血改变。决定采用门静脉支架进行抢救,以防止不可逆的肝损害。手术成功,临床效果满意。结论:本文总结了经皮门静脉支架置入术治疗急性肝衰竭患者术后门静脉高度狭窄的临床疗效。
{"title":"Portal vein stent to save the day.","authors":"Panagiotis Grigoropoulos, Vasilina Tsemelidi, Orfeas Varvarelis, Antonios Vezakis, Achilles Chatziioannou, Miltiadis Krokidis","doi":"10.1186/s42155-025-00586-3","DOIUrl":"10.1186/s42155-025-00586-3","url":null,"abstract":"<p><strong>Background: </strong>Post-operative portal vein stenosis/occlusion is a relatively common and life-threatening condition. Clinical outcomes depend on the early diagnosis and the appropriate management.</p><p><strong>Case presentation: </strong>A 78-year-old female developed portal vein high grade stenosis after resection of an ampullary cholangiocarcinoma. The patient presented with acute liver failure and impaired coagulation function. Imaging confirmed transient ischemic changes of the hepatic parenchyma. Salvage attempt with a portal venous stent was decided to prevent irreversible liver damage. The procedure was successful with a satisfactory clinical outcome.</p><p><strong>Conclusions: </strong>The paper offers a summary of the clinical benefit from percutaneous portal venous stent placement in case of post operative high grade portal vein stenosis in a patient with acute liver failure.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"69"},"PeriodicalIF":1.5,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12397468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144977457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial snare technique for transfemoral repositioning of malpositioned central venous port catheter. 人工圈套技术在经股中心静脉口置管复位中的应用。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-08-22 DOI: 10.1186/s42155-025-00563-w
Taha Yusuf Kuzan, Rüçhan Anbar

Subcutaneously implanted port catheters are increasingly used in the management of long-term chemotherapy and provide great comfort to oncology patients. Although central venous ports are implanted with high technical success and low complication rates, catheter malposition may occur, resulting in port dysfunction. Various techniques exist for repositioning malpositioned catheters. This report describes the use of an artificial snare technique for the repositioning of a central venous port catheter that was identified as malpositioned six months following its insertion.

在长期化疗的管理中越来越多地使用皮下植入的port导管,为肿瘤患者提供了极大的安慰。虽然中心静脉端口植入技术成功率高,并发症发生率低,但可能发生导管错位,导致端口功能障碍。存在多种重新定位错位导管的技术。本报告描述了使用人工圈套技术重新定位中心静脉端口导管,该导管在插入六个月后被确定为错位。
{"title":"Artificial snare technique for transfemoral repositioning of malpositioned central venous port catheter.","authors":"Taha Yusuf Kuzan, Rüçhan Anbar","doi":"10.1186/s42155-025-00563-w","DOIUrl":"10.1186/s42155-025-00563-w","url":null,"abstract":"<p><p>Subcutaneously implanted port catheters are increasingly used in the management of long-term chemotherapy and provide great comfort to oncology patients. Although central venous ports are implanted with high technical success and low complication rates, catheter malposition may occur, resulting in port dysfunction. Various techniques exist for repositioning malpositioned catheters. This report describes the use of an artificial snare technique for the repositioning of a central venous port catheter that was identified as malpositioned six months following its insertion.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"68"},"PeriodicalIF":1.5,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12370592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144978239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early percutaneous thrombolysis for AVF thrombosis: symptom duration as a predictor of endovascular salvage. 早期经皮溶栓治疗AVF血栓:症状持续时间作为血管内抢救的预测因子。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-08-19 DOI: 10.1186/s42155-025-00587-2
Ismail Taskent, Guler Gulsen Ersoy

Background: Arteriovenous fistula (AVF) thrombosis remains a critical complication in hemodialysis (HD) patients, often leading to treatment delays and requiring urgent intervention. While endovascular therapy (EVT) is commonly employed, less invasive strategies such as percutaneous thrombolytic therapy are gaining attention due to their potential to restore patency and avoid more complex procedures. This study assessed the effectiveness of percutaneous thrombolytic therapy in acute AVF thrombosis and explored key predictors associated with the need for subsequent endovascular intervention.

Methods: This retrospective study included 42 patients who underwent ultrasound-guided percutaneous thrombolytic therapy using low-dose alteplase (3-5 mg). Technical and clinical success, complication rates, and the need for additional EVT were assessed. Statistical analyses including logistic regression and ROC analysis were used to determine independent predictors for EVT.

Results: The clinical success rate was 97.6%, with 69% of patients achieving AVF patency without EVT. Symptom duration emerged as the strongest predictor for EVT; patients with symptoms > 2.5 days had significantly higher EVT rates (p = 0.01). Each additional day of symptoms increased the odds of requiring EVT by 88.5% (OR = 1.885, p = 0.012). Female patients were also more likely to require EVT than males (p = 0.005). No significant associations were found for age, BMI, or fistula characteristics.

Conclusion: Percutaneous thrombolytic therapy is a highly effective and minimally invasive option for acute AVF thrombosis. Symptom duration > 2.5 days is a key threshold predicting the need for EVT, highlighting the critical importance of early intervention. These findings may inform clinical decision-making and optimize access salvage strategies in dialysis patients.

背景:动静脉瘘(AVF)血栓形成仍然是血液透析(HD)患者的一个重要并发症,经常导致治疗延误并需要紧急干预。虽然血管内治疗(EVT)是常用的治疗方法,但侵入性较小的策略,如经皮溶栓治疗,由于其恢复通畅和避免更复杂的手术的潜力而受到关注。本研究评估了经皮溶栓治疗急性AVF血栓形成的有效性,并探讨了与后续血管内介入治疗需求相关的关键预测因素。方法:本回顾性研究纳入42例超声引导下经皮小剂量阿替普酶(3- 5mg)溶栓治疗的患者。评估了技术和临床成功率、并发症发生率以及额外EVT的必要性。统计分析包括逻辑回归和ROC分析,以确定EVT的独立预测因子。结果:临床成功率为97.6%,69%的患者达到AVF通畅,无EVT。症状持续时间是EVT的最强预测因子;出现症状> 2.5 d的患者EVT发生率显著高于对照组(p = 0.01)。症状每增加一天,需要EVT的几率增加88.5% (OR = 1.885, p = 0.012)。女性患者也比男性患者更可能需要EVT (p = 0.005)。未发现年龄、BMI或瘘管特征有显著相关性。结论:经皮溶栓治疗急性AVF血栓是一种高效、微创的治疗方法。症状持续时间> 2.5天是预测EVT需要的关键阈值,突出了早期干预的重要性。这些发现可以为临床决策提供信息,并优化透析患者的准入挽救策略。
{"title":"Early percutaneous thrombolysis for AVF thrombosis: symptom duration as a predictor of endovascular salvage.","authors":"Ismail Taskent, Guler Gulsen Ersoy","doi":"10.1186/s42155-025-00587-2","DOIUrl":"10.1186/s42155-025-00587-2","url":null,"abstract":"<p><strong>Background: </strong>Arteriovenous fistula (AVF) thrombosis remains a critical complication in hemodialysis (HD) patients, often leading to treatment delays and requiring urgent intervention. While endovascular therapy (EVT) is commonly employed, less invasive strategies such as percutaneous thrombolytic therapy are gaining attention due to their potential to restore patency and avoid more complex procedures. This study assessed the effectiveness of percutaneous thrombolytic therapy in acute AVF thrombosis and explored key predictors associated with the need for subsequent endovascular intervention.</p><p><strong>Methods: </strong>This retrospective study included 42 patients who underwent ultrasound-guided percutaneous thrombolytic therapy using low-dose alteplase (3-5 mg). Technical and clinical success, complication rates, and the need for additional EVT were assessed. Statistical analyses including logistic regression and ROC analysis were used to determine independent predictors for EVT.</p><p><strong>Results: </strong>The clinical success rate was 97.6%, with 69% of patients achieving AVF patency without EVT. Symptom duration emerged as the strongest predictor for EVT; patients with symptoms > 2.5 days had significantly higher EVT rates (p = 0.01). Each additional day of symptoms increased the odds of requiring EVT by 88.5% (OR = 1.885, p = 0.012). Female patients were also more likely to require EVT than males (p = 0.005). No significant associations were found for age, BMI, or fistula characteristics.</p><p><strong>Conclusion: </strong>Percutaneous thrombolytic therapy is a highly effective and minimally invasive option for acute AVF thrombosis. Symptom duration > 2.5 days is a key threshold predicting the need for EVT, highlighting the critical importance of early intervention. These findings may inform clinical decision-making and optimize access salvage strategies in dialysis patients.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"67"},"PeriodicalIF":1.5,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144876724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Textile-based radiation protection of staff during fluoroscopic guided interventions: enhancing durability, comfort and safety. 透视引导介入手术中工作人员基于纺织品的辐射防护:增强耐用性、舒适性和安全性。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-08-18 DOI: 10.1186/s42155-025-00585-4
Fredrik Gellerstedt, Petra Apell, Ziv J Haskal
{"title":"Textile-based radiation protection of staff during fluoroscopic guided interventions: enhancing durability, comfort and safety.","authors":"Fredrik Gellerstedt, Petra Apell, Ziv J Haskal","doi":"10.1186/s42155-025-00585-4","DOIUrl":"10.1186/s42155-025-00585-4","url":null,"abstract":"","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"66"},"PeriodicalIF":1.5,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144876725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the impact of nodular calcification on clinical outcome after drug-coated balloon angioplasty for femoropopliteal lesions. 药包球囊血管成形术治疗股腘动脉病变后结节性钙化对临床疗效的影响分析。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-08-16 DOI: 10.1186/s42155-025-00583-6
Shinsuke Mori, Mitsuyoshi Takahara, Tatsuya Nakama, Kazuki Tobita, Naoki Hayakawa, Yo Iwata, Kazunori Horie, Kenji Suzuki, Norihiro Kobayashi, Yoshiaki Ito

Purpose: This study aimed to reveal the impact of nodular calcification (NC) on restenosis risk in patients undergoing femoropopliteal drug-coated balloon (DCB) angioplasty for symptomatic atherosclerotic peripheral artery disease.

Methods: We retrospectively analyzed 568 patients who underwent endovascular therapy with DCB for de novo femoropopliteal lesions under intravascular ultrasound guidance between November 2017 and February 2021 at seven cardiovascular centers in Japan. Patients with lesions without calcification were excluded from the study. The patients were classified into two groups based on the presence or absence of NC: the NC [ +] group (n = 200) and the NC [-] group (n = 368). The main outcome was the primary patency at 3 years. Cox proportional hazards analysis was used to determine whether NC was an independent predictor of clinical outcomes.

Results: The 3-year primary patency rates were significantly lower in the NC [ +] group than in the NC [-] group (53.8% vs. 65.8%, p = 0.001). After multivariate analysis, the presence of NC was independently associated with restenosis risk; the adjusted hazard ratio was 1.61 (95% confidence interval 1.15 to 2.26, p = 0.006).

Conclusion: The NC is an independent predictor of restenosis in patients undergoing DCB angioplasty for femoropopliteal lesions. Patients with NC had a significantly lower primary patency, highlighting their negative impact on clinical outcomes. Further research is required to establish evidence-based strategies for managing calcified femoropopliteal lesions.

目的:本研究旨在揭示结节钙化(NC)对行股腘药物包被球囊(DCB)血管成形术治疗症状性动脉粥样硬化性外周动脉疾病患者再狭窄风险的影响。方法:我们回顾性分析了2017年11月至2021年2月在日本7个心血管中心在血管内超声引导下接受DCB血管内治疗新发股腘病变的568例患者。无钙化病变的患者被排除在研究之外。根据有无NC分为两组:NC[+]组(n = 200)和NC[-]组(n = 368)。主要结果是3年时的原发性通畅。采用Cox比例风险分析来确定NC是否是临床结果的独立预测因子。结果:NC[+]组3年原发性通畅率明显低于NC[-]组(53.8% vs. 65.8%, p = 0.001)。多因素分析显示,NC的存在与再狭窄风险独立相关;校正后的风险比为1.61(95%置信区间1.15 ~ 2.26,p = 0.006)。结论:NC是股腘动脉病变行DCB血管成形术患者再狭窄的独立预测因子。NC患者的原发性通畅率明显较低,这突出了其对临床结果的负面影响。需要进一步的研究来建立以证据为基础的治疗股腘动脉钙化病变的策略。
{"title":"Analysis of the impact of nodular calcification on clinical outcome after drug-coated balloon angioplasty for femoropopliteal lesions.","authors":"Shinsuke Mori, Mitsuyoshi Takahara, Tatsuya Nakama, Kazuki Tobita, Naoki Hayakawa, Yo Iwata, Kazunori Horie, Kenji Suzuki, Norihiro Kobayashi, Yoshiaki Ito","doi":"10.1186/s42155-025-00583-6","DOIUrl":"10.1186/s42155-025-00583-6","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to reveal the impact of nodular calcification (NC) on restenosis risk in patients undergoing femoropopliteal drug-coated balloon (DCB) angioplasty for symptomatic atherosclerotic peripheral artery disease.</p><p><strong>Methods: </strong>We retrospectively analyzed 568 patients who underwent endovascular therapy with DCB for de novo femoropopliteal lesions under intravascular ultrasound guidance between November 2017 and February 2021 at seven cardiovascular centers in Japan. Patients with lesions without calcification were excluded from the study. The patients were classified into two groups based on the presence or absence of NC: the NC [ +] group (n = 200) and the NC [-] group (n = 368). The main outcome was the primary patency at 3 years. Cox proportional hazards analysis was used to determine whether NC was an independent predictor of clinical outcomes.</p><p><strong>Results: </strong>The 3-year primary patency rates were significantly lower in the NC [ +] group than in the NC [-] group (53.8% vs. 65.8%, p = 0.001). After multivariate analysis, the presence of NC was independently associated with restenosis risk; the adjusted hazard ratio was 1.61 (95% confidence interval 1.15 to 2.26, p = 0.006).</p><p><strong>Conclusion: </strong>The NC is an independent predictor of restenosis in patients undergoing DCB angioplasty for femoropopliteal lesions. Patients with NC had a significantly lower primary patency, highlighting their negative impact on clinical outcomes. Further research is required to establish evidence-based strategies for managing calcified femoropopliteal lesions.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"65"},"PeriodicalIF":1.5,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12357817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IVUS-guided wiring using the deep vein as a landmark (IDEAL) technique for treating chronic total occlusions in peripheral artery disease. ivus引导下使用深静脉作为路标(IDEAL)技术治疗外周动脉疾病慢性全闭塞。
IF 1.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-08-15 DOI: 10.1186/s42155-025-00584-5
Yohei Ueno, Mitsuo Sobajima, Teruhiko Imamura, Hiroshi Onoda, Ryuichi Ushijima, Hiroshi Ueno, Koichiro Kinugawa

Background: Endovascular therapy (EVT) is a well-established revascularization strategy for patients with peripheral artery disease. However, achieving optimal wire crossing in complex chronic total occlusion lesions remains technically challenging. Intravascular ultrasound (IVUS)-guided wiring facilitates safer and more effective procedures. However, aligning IVUS findings with fluoroscopic imaging is challenging due to catheter rotation. We report a novel technique-termed the IDEAL technique-that leverages the deep vein as an anatomical landmark to correct IVUS rotational orientation.

Case presentation: A 76-year-old female presented with chronic limb-threatening ischemia in the right toe. Contrast-enhanced computed tomography revealed a chronic total occlusion in the right superficial femoral artery. EVT was performed via the right common femoral artery. IVUS revealed that the first guidewire had entered the subintimal space partway through its course. Using preprocedural computed tomography, the deep vein was identified and its clock-face position relative to the artery was determined. This anatomical landmark enabled correction of IVUS image rotation, allowing accurate re-direction of a second guidewire under fluoroscopic guidance, thereby successfully crossing into the intraplaque lumen.

Conclusions: The IDEAL technique quickly provides anatomical orientation by utilizing the deep vein as a landmark during IVUS-guided wiring-making it, quite literally, ideal.

背景:血管内治疗(EVT)是一种公认的外周动脉疾病患者血运重建策略。然而,在复杂的慢性全闭塞病变中实现最佳导线交叉在技术上仍然具有挑战性。血管内超声(IVUS)引导的布线有助于更安全、更有效的手术。然而,由于导管旋转,将IVUS结果与透视成像相一致是具有挑战性的。我们报告了一种称为IDEAL技术的新技术,该技术利用深静脉作为解剖标志来纠正IVUS旋转方向。病例介绍:一名76岁女性,右脚趾出现慢性肢体缺血。增强计算机断层扫描显示右股浅动脉慢性全闭塞。经右股总动脉行EVT。IVUS显示第一根导丝在其行进过程中进入内膜下空间。通过术前计算机断层扫描,确定深静脉并确定其相对于动脉的时钟面位置。这一解剖标志能够校正IVUS图像旋转,允许在透视引导下精确地重新定向第二根导丝,从而成功地进入斑块内腔。结论:IDEAL技术通过利用深静脉作为ivus引导下的地标,快速提供解剖定位,使其成为理想的技术。
{"title":"IVUS-guided wiring using the deep vein as a landmark (IDEAL) technique for treating chronic total occlusions in peripheral artery disease.","authors":"Yohei Ueno, Mitsuo Sobajima, Teruhiko Imamura, Hiroshi Onoda, Ryuichi Ushijima, Hiroshi Ueno, Koichiro Kinugawa","doi":"10.1186/s42155-025-00584-5","DOIUrl":"10.1186/s42155-025-00584-5","url":null,"abstract":"<p><strong>Background: </strong>Endovascular therapy (EVT) is a well-established revascularization strategy for patients with peripheral artery disease. However, achieving optimal wire crossing in complex chronic total occlusion lesions remains technically challenging. Intravascular ultrasound (IVUS)-guided wiring facilitates safer and more effective procedures. However, aligning IVUS findings with fluoroscopic imaging is challenging due to catheter rotation. We report a novel technique-termed the IDEAL technique-that leverages the deep vein as an anatomical landmark to correct IVUS rotational orientation.</p><p><strong>Case presentation: </strong>A 76-year-old female presented with chronic limb-threatening ischemia in the right toe. Contrast-enhanced computed tomography revealed a chronic total occlusion in the right superficial femoral artery. EVT was performed via the right common femoral artery. IVUS revealed that the first guidewire had entered the subintimal space partway through its course. Using preprocedural computed tomography, the deep vein was identified and its clock-face position relative to the artery was determined. This anatomical landmark enabled correction of IVUS image rotation, allowing accurate re-direction of a second guidewire under fluoroscopic guidance, thereby successfully crossing into the intraplaque lumen.</p><p><strong>Conclusions: </strong>The IDEAL technique quickly provides anatomical orientation by utilizing the deep vein as a landmark during IVUS-guided wiring-making it, quite literally, ideal.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":"8 1","pages":"64"},"PeriodicalIF":1.5,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12354929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
CVIR Endovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1